美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
46287-020-01	46287-020	HUMAN PRESCRIPTION DRUG	CaroSpir	CaroSpir	SUSPENSION	ORAL	20170804	N/A	NDA	NDA209478	CMP Pharma, Inc.	SPIRONOLACTONE	25 mg/5mL	473 mL in 1 BOTTLE (46287-020-01)
46287-020-04	46287-020	HUMAN PRESCRIPTION DRUG	CaroSpir	CaroSpir	SUSPENSION	ORAL	20170804	N/A	NDA	NDA209478	CMP Pharma, Inc.	SPIRONOLACTONE	25 mg/5mL	118 mL in 1 BOTTLE (46287-020-04)
46287-020-50	46287-020	HUMAN PRESCRIPTION DRUG	CaroSpir	CaroSpir	SUSPENSION	ORAL	20210715	N/A	NDA	NDA209478	CMP Pharma, Inc.	SPIRONOLACTONE	25 mg/5mL	10 CUP, UNIT-DOSE in 1 CARTON (46287-020-50) / 5 mL in 1 CUP, UNIT-DOSE
17856-0120-1	17856-0120	HUMAN PRESCRIPTION DRUG	CaroSpir	CaroSpir	SUSPENSION	ORAL	20240412	N/A	NDA	NDA209478	ATLANTIC BIOLOGICALS CORP.	SPIRONOLACTONE	25 mg/5mL	72 CUP in 1 BOX (17856-0120-1) / 2.5 mL in 1 CUP (17856-0120-2)
17856-1133-1	17856-1133	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE	spironolactone	SUSPENSION	ORAL	20240603	N/A	NDA AUTHORIZED GENERIC	NDA209478	ATLANTIC BIOLOGICALS CORP.	SPIRONOLACTONE	25 mg/5mL	1 SYRINGE in 1 BAG (17856-1133-1) / 2.5 mL in 1 SYRINGE
0574-1133-04	0574-1133	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE	spironolactone	SUSPENSION	ORAL	20231031	N/A	NDA AUTHORIZED GENERIC	NDA209478	Padagis US LLC	SPIRONOLACTONE	25 mg/5mL	118 mL in 1 BOTTLE (0574-1133-04)
0574-1133-10	0574-1133	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE	spironolactone	SUSPENSION	ORAL	20231031	N/A	NDA AUTHORIZED GENERIC	NDA209478	Padagis US LLC	SPIRONOLACTONE	25 mg/5mL	10 CUP, UNIT-DOSE in 1 CARTON (0574-1133-10) / 5 mL in 1 CUP, UNIT-DOSE (0574-1133-05)
0574-1133-16	0574-1133	HUMAN PRESCRIPTION DRUG	SPIRONOLACTONE	spironolactone	SUSPENSION	ORAL	20231031	N/A	NDA AUTHORIZED GENERIC	NDA209478	Padagis US LLC	SPIRONOLACTONE	25 mg/5mL	473 mL in 1 BOTTLE (0574-1133-16)